HomeCME Courses AvailableAbout UsContact UsPrint

:: MRSA Home

:: Program Information

:: Publisher's Forward

:: Introduction &    
   Epidemiology

:: Comparison of CA- &
   HA-MRSA

:: Diagnosis

:: Management & Treatment

:: Preventing the Spread
   of MRSA

:: Case Studies

:: Summary

:: Appendix A

:: Appendix B

:: Appendix C

:: Appendix D

:: Appendix E

:: CME Test & Evaluation

Preventing the Spread of MRSA

DR. CORDOVER: We are being told that community-associated MRSA infections are actually being disseminated in hospitals and emergency departments. If this is true, how prevalent is it, and aren’t gloves and alcohol-based hand foams for surface cleaning enough to prevent the transmission of community-associated MRSA?

DR. FOX: This is a great question, especially for health care workers. Let me try and tackle the first portionof this question which I briefly alluded to before. Surprisingly, about 50% of all the MRSA that is in hospitals these days is actually coming in from the community. This is held up in several studies and publications so far. The transmission of MRSA is no different between the old hospital-associated strain of MRSA and the community-associated strain. It is true that we are adopting standard precautions which asks us to wash our hands with running water and /or alcohol-based hand gels before going to a patient room and after going to a patient room, and in circumstances where there are wounds or incision-and-drainages to be accomplished, to wear gloves. That does eliminate and prevent a lot of transmission of community-associated MRSA.

MRSA is susceptible to the alcohol-based hand gels and certainly if you wanted to wash your hands for 30 seconds or more, then you will be effective in reducing the transmission of MRSA. There can be, as I alluded to earlier, contaminated surfaces and you do have to be somewhat vigilant of the contaminated surfaces. The standard hospital disinfectants are effective for killing MRSA on environmental surfaces so I believe it is important to have a protocol for patients seen in the emergency department to have theirbed or their area wiped down after the patient leaves that particular room or particular area.

* * * * * * * * * * * *

DR. CORDOVER: How do I keep from bringing this home with me? Can I bring MRSA home on my scrubs? Do I need to be decolonized?

DR. FOX: There are some things that you can do to prevent bringing this home with you. We’ve already discussed using alcohol-based hand gels and wearing gloves. I think we know that with the environment as a potential source, if you bring scrubs home from your emergency department visit, this does run the risk of bringing this organism into your home. I would strongly encourage physicians not to wear their work clothes home if they’re concerned about community-associated MRSA. It would be ideal for them to change into scrubs, wear the scrubs, and then have the scrubs laundered. It’s fortunate that having laundry water temperatures greater than 180 degrees is effective in killing resistant Staphylococcus and hence we can trust that laundering scrubs is effective.

I would also advise that emergency department physicians certainly do a good hand washing before they leave their shift. Some of you may feel compelled to take a full shower when you leave or when you get home. This is not unreasonable. There are some disinfectant soaps that can be used to reduce your risk of community-associated MRSA and the disinfectant soaps also are occasionally used by infectious disease and other healthcare providers for decolonization regimens. These antimicrobial soaps are Phisohex-based soaps or chlorhexidine 2%-based soaps, or much less likely, betadine-based soaps.

Now, if you’re going to shower or lather with these once a week or twice a week, there is a trick that one needs to know for using these antimicrobial soaps, and this is something that really is not taught very well in journal articles. In order for disinfectant soaps to work, they have to stay in contact with the skin surface for 3 to 5 minutes. You’re all familiar with doing a preparation for surgery and we try very hard to allow the betadine or the chlorhexidine product to dry before inserting any scalpel or any needle. The same is really true when applying chlorhexidine or Phisohex to the skin. I generally recommend that people shower, get themselves wet, and then apply the antimicrobial soap over their body. I ask people to turn the water off or to go out of the main stream of the water and to count to 200, or 180 for 3 minutes, and then to rinse. It is that contact time that allows the antimicrobial soap to be effective. Too often, if people do use antimicrobial soaps, they will just rub-a-dub-dub, scrub it on and wash it right off, and that is defeating the purpose of using an antimicrobial soap.

* * * * * * * * * * * *

DR. CORDOVER: It is quite common to see recently hospitalized or nursing home patients come into the ED with fever, confusion or other signs of infection. Are there risk factors that would lead us to suspect HA-MRSA infection as opposed to Pneumococcus, E. coli or Pseudomonas?

DR. FOX: This is an excellent general question. It is important to note that any patient that resides in a long term health care facility is at risk for hospital-associated resistant Staphylococcal infections and the presence of multi-drug resistant bacteria. So in general our approach to treatment with anti-infective therapy is different than the approach to patients that would present from the community. If you believe the patient has a hospital and health care associated infection, we’re more likely to empirically cover for resistant gram negative bacteria and for hospital-associated methicillin-resistant Staph. On the other hand, patients that are coming from assisted living that are not in hospital situations and are not frequently with health care providers, probably do not fit into this category and can be treated more likely as community-associated infections.

Methicillin-resistant Staph is also becoming a factor in nursing home patients in decubitus ulcers in these patients. We have to assume if a patient is living in a nursing home, if they have a decubitus ulcer, and there’s a surrounding area of cellulitis, that methicillin-resistant Staph is the predominant organism. Some of these decubitus ulcers may be polymicrobial. If they have been chronic and are on ischemic limbs, there may be methicillin-resistant Staph, anaerobic organisms, and some gram negative rods and even resistant gram negative rods and you do have to factor these circumstances when deciding on effective antimicrobial therapy. In patients coming from nursing homes with decubitus ulcers, you certainly should consider them as being at risk for having MRSA-based infection and prescribe antibiotics accordingly.

DR. CORDOVER: What antibiotics should we use to treat these patients? Should we start
anti-Staph drugs empirically?

DR. FOX: The antibiotics that we previously mentioned for community-associated MRSA are not the kind of antibiotics that we’re choosing for individuals coming from extended care facilities or for patients that may be seriously ill enough to require hospitalization. Under those circumstances, we would generally utilize intravenous antibiotics. The mainstay of intravenous therapy has been vancomycin for the past 40 years. Until the early 2000’s this was the only agent we had that was effective for methicillinresistant Staphylococcus. We are fortunate now that there are a few new anti-infective agents that are effective for Staphylococcus. These include linezolid, daptomycin, and soon to be coming, dalvabancin and telavancin, two glycopeptide antibiotics likely to be approved by the Food and Drug Administration.

* * * * * * * * * * * *

DR. CORDOVER: How do you choose between vancomycin and daptomycin and linezolid for treatment when patients are admitted to the hospital?

DR. FOX: These are difficult decisions and really require some degree of expertise and some degree of assessment of the patient’s severity of illness. I believe it’s beyond the scope of this particular CME opportunity for me to go into the nuances of these various drugs, but these are three agents that are available as choices for us for treatment of hospital-associated patients.

One possible advantage of linezolid is the possibility of an intravenous to oral step-down therapy for patients that might have brief hospitalizations that would be discharged on the same anti-infective agent. These agents may also be considered for the treatment of patients in extended care facilities without the need for patients to be hospitalized. It’s very likely that the long-term care facility does have the capacity to administer intravenous antibiotics in a once or twice daily fashion. Many of these patients will also be elderly and have elevated serum creatinine so that vancomycin may be dosed on a once-aday basis instead of a twice-a day basis.

Certainly, patients presenting to the emergency room who you think would need to be admitted to the hospital, should ideally have blood cultures performed before antibiotic agents are given. Indeed, the mortality of patients with presumed sepsis from Staphylococcus and other organisms is dependent in some degree on the timing and timely administration of anti infective therapy. Recent critical care literature tells us that for every hour of delay in the initiation of anti-infective therapy for someone with a sepsis syndrome or sepsis, there is an 8% increase in mortality. So it behooves us as emergency department physicians to try to recognize sepsis cases in an early fashion and subsequently administer antibiotics after blood cultures have been drawn appropriately.

©2008 TIV, Inc. All rights reserved. Produced by TIV, Inc.